SN30000
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Introduction: Chemotherapy is often limited by resistant subpopulations of tumor cells. Tumor hypoxia contributes to resistance…
Triple-negative breast cancer (TNBC) is an aggressive malignancy with poor clinical outcome and few validated drug targets. Two…
Background: NADPH:cytochrome P450 oxidoreductase (POR) catalyzes one-electron reduction of hypoxia-activated prodrugs (HAP…
Hypoxia is more severe in tumors than normal tissues, and contributes to tumor progression and therapeutic resistance. It is…
e13597 Background: SN30000 (CEN-209), a benzotriazine-N-oxide, is a second generation analogue of tirapazamine (TPZ) and is…
Proceedings: AACR 102nd Annual Meeting 2011‐‐ Apr 2‐6, 2011; Orlando, FL
Introduction: SN30000 (CEN-209) is a structural…